Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis

Rajiv Kumar, Patrick T Bunn, Siddharth Sankar Singh, Susanna S Ng, Marcela Montes de Oca, Fabian de Labastida Rivera, Shashi Bhushan Chauhan, Neetu Singh, Rebecca J Faleiro, Chelsea L Edwards, Meru Sheel

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Type I interferons (IFNs) play critical roles in anti-viral and anti-tumor immunity. However, they also suppress protective immune responses in some infectious diseases.
    Original languageEnglish
    Pages (from-to)2512-2525
    JournalCell Reports
    Volume30
    DOIs
    Publication statusPublished - 2020

    Fingerprint

    Dive into the research topics of 'Type I Interferons Suppress Anti-parasitic Immunity and Can Be Targeted to Improve Treatment of Visceral Leishmaniasis'. Together they form a unique fingerprint.

    Cite this